Blackstone, Bain to bid for Mitsubishi pharma unit - Reuters
Private equity firms Blackstone (NYSE:BX) and Bain Capital are among final bidders for Mitsubishi Chemical ...
EU drugs regulator backs Mounjaro's sleep apnea use without fresh approval for Lilly
The European Medicines Agency has allowed Eli Lilly to update the product label of its weight-loss drug Mounjaro to show it ...
devdiscourse2h
Global Health Developments: From Pharma Deals to Drug Policy Updates
In the rapidly evolving health sector, Blackstone and Bain Capital are vying to acquire Mitsubishi Tanabe Pharma, potentially valuing the Japanese subsidiary at up to $3.5 billion. Sources reveal that ...
Business Standard4h
Blackstone, Bain to bid for Mitsubishi pharma unit in up to $3.5 bn deal
Global private equity firms Blackstone and Bain Capital are among final bidders for Mitsubishi Tanabe Pharma, a unit of Japan ...
Blackstone, Bain to bid for Mitsubishi pharma unit in up to $3.5 billion deal, sources say
Global private equity firms Blackstone and Bain Capital are among final bidders for Mitsubishi Tanabe Pharma, a unit of Japan ...
The Globe and Mail15h
Blackstone and Bain Capital among final bidders for Mitsubishi pharma unit, sources say
Global private equity firms Blackstone and Bain Capital are among final bidders for Mitsubishi Tanabe Pharma, a unit of Japan ...
Business Insider1d
Dewpoint Therapeutics and ConcertAI Announce the First Phase of their Translational Oncology Partnership
Through collaborations with Bayer, Novo Nordisk, Evotec, and Mitsubishi Tanabe Pharma Corporation, Dewpoint pushes the boundaries to accelerate the translation of condensate biology into medicine for ...
manilatimes4d
Actinogen randomizes first US participant in XanaMIA phase 2b/3 Alzheimer's disease trial
Late-stage trial in Alzheimer's opens 10 sites in US, with results due in 2025 and 2026 Appoints US-based Chief Commercial ...
BioWorld6d
Dewpoint and Mitsubishi ink $480M ALS research collaboration
Dewpoint Therapeutics Inc. and Mitsubishi Tanabe Pharma Corp. have entered a research collaboration worth up to $480 million ...
FiercePharma7d
Fierce Pharma Asia—Sanofi's $1B manufacturing base; GSK's ADC deal, Shingrix recalibration in China
Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in ...
Amarillo Biosciences Signs Memorandum of Understanding for Collaboration with Taiwan Tanabe Seiyaku
Amarillo Biosciences (OTCMKTS:AMAR) recently entered into a Memorandum of Understanding (MOU) with Taiwan Tanabe Seiyaku Co., Ltd., a corporation majority-owned by Mitsubishi Tanabe Pharma Corporation ...